Dr. Bhisham Chera, MD of the University of North Carolina Hospitals, Chapel Hill discusses the scientific rationale behind the attempt to de-intensify chemoradiotherapy for HPV-associated Carcinoma at ASTRO Head and Neck Conference.
Advertisement
[the_ad id="32629"]